Anthocyanins as inflammatory modulators and the role of the gut microbiota

Journal of Nutritional Biochemistry

Volumn 33, Issue , 2016, Pages 1-7

  Morais, Carina Almeida ^a   de Rosso, Veridiana Vera ^a   Estadella, Débora ^a   Pisani, Luciana Pellegrini ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anthocyanin; Bifidobacterium; Inflammation; Microbiota; NF B

Indexed keywords

ANTHOCYANIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4; NONSTEROID ANTIINFLAMMATORY AGENT;

ANTIINFLAMMATORY ACTIVITY; BIFIDOBACTERIUM; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INTESTINE FLORA; MULTICENTER STUDY (TOPIC); NONHUMAN; PERMEABILITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; DIETARY SUPPLEMENT; DYSBIOSIS; FRUIT; FUNCTIONAL FOOD; IMMUNOLOGY; METABOLISM; MICROBIOLOGY;

ANIMALS; ANTHOCYANINS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DIETARY SUPPLEMENTS; DYSBIOSIS; FRUIT; FUNCTIONAL FOOD; GASTROINTESTINAL MICROBIOME; HUMANS; MODELS, BIOLOGICAL;

EID: 84961153713     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2015.11.008     Document Type: Review

References (82)

1. Albenberg L.G., Wu G.D. Diet and the intestinal microbiome: associations, functions, and implications for health and disease. Gastroenterology 2014, 146(6):1564-1572.
2. Fukuda S., Ohno H. Gut microbiome and metabolic diseases. Semin Immunopathol 2014, 36(1):103-114.
3. Holmes E., Li J.V., Athanasiou T., Ashrafian H., Nicholson J.K. Understanding the role of gut microbiome-host metabolic signal disruption in health and disease. Trends Microbiol 2011, 19(7):349-359.
4. Rautava S., Collado M.C., Salminen S., Isolauri E. Probiotics modulate host-microbe interaction in the placenta and fetal gut: a randomized, double-blind, placebo-controlled trial. Neonatology 2012, 102(3):178-184.
5. Ding S., Chi M.M., Scull B.P., Rigby R., Schwerbrock N.M., Magness S., et al. High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS One 2010, 5(8):e12191.
6. Kim K.A., Gu W., Lee I.A., Joh E.H., Kim D.H. High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One 2012, 7(10):e47713.
7. Mutlu E., Keshavarzian A., Engen P., Forsyth C.B., Sikaroodi M., Gillevet P. Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats. Alcohol Clin Exp Res 2009, 33(10):1836-1846.
8. Lu Y.C., Yeh W.C., Ohashi P.S. LPS/TLR4 signal transduction pathway. Cytokine 2008, 42(2):145-151.
9. Villena J., Kitazawa H. Modulation of intestinal TLR4-inflammatory signaling pathways by probiotic microorganisms: lessons learned from Lactobacillus jensenii TL2937. Front Immunol 2014, 14(4):512.
10. Cani P.D., Neyrinck A.M., Fava F., Knauf C., Burcelin R.G., Tuohy K.M., et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007, 50(11):2374-2383.
11. Moreira A.P.B., Texeira T.F.S., Ferreira A.B., Peluzio M.C.G., Alfenas R.C.G. Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. Br J Nutr 2012, 108(5):801-809.
12. Tilg H., Moschen A.R. Microbiota and diabetes: an evolving relationship. Gut 2014, 63(9):1513-1521.
13. Espley R.V., Butts C.A., Laing W.A., Martell S., Smith H., McGhie T.K., et al. Dietary flavonoids from modified apple reduce inflammation markers and modulate gut microbiota in mice. J Nutr 2014, 144(2):146-154.
14. Neyrinck A.M., Van Hée V.F., Bindels L.B., De Backer F., Cani P.D., Delzenne N.M. Polyphenol-rich extract of pomegranate peel alleviates tissue inflammation and hypercholesterolaemia in high-fat diet-induced obese mice: potential implication of the gut microbiota. Br J Nutr 2013, 109(5):802-809.
15. Rahman I., Chung S. Dietary polyphenols, deacetylases and chromatin remodeling in inflammation. J Nutrigenet Nutrigenomics 2010, 3(4-6):220-230.
16. Vauzour D. Dietary polyphenols as modulators of brain functions: biological actions and molecular mechanisms underpinning their beneficial effects. Oxid Med Cell Longev 2012, 2012:1-16.
17. Kong J.M., Chia L.S., Goh N.K., Chia T.F., Brouillard R. Analysis and biological activities of anthocyanins. Phytochemistry 2003, 64(5):923-933.
18. Erratum in. Phytochemistry 2008, 69(9):1939-1940. Review.
19. Riso P., Klimis-Zacas D., Del Bo' C., Martini D., Campolo J., Vendrame S., et al. Effect of a wild blueberry (Vaccinium angustifolium) drink intervention on markers of oxidative stress, inflammation and endothelial function in humans with cardiovascular risk factors. Eur J Nutr 2013, 52(3):949-961.
20. Guerra J.F., Magalhães C.L., Costa D.C., Silva M.E., Pedrosa M.L. Dietary açai modulates ROS production by neutrophils and gene expression of liver antioxidant enzymes in rats. J Clin Biochem Nutr 2011, 49(3):188-194.
21. Esposito D., Chen A., Grace M.H., Komarnytsky S., Lila M.A. Inhibitory effects of wild blueberry anthocyanins and other flavonoids on biomarkers of acute and chronic inflammation in vitro. J Agric Food Chem 2014, 62(29):7022-7028.
22. Lee S.G., Kim B., Yang Y., Pham T.X., Park Y.K., Manatou J., et al. Berry anthocyanins suppress the expression and secretion of proinflammatory mediators in macrophages by inhibiting nuclear translocation of NF-κB independent of NRF2-mediated mechanism. J Nutr Biochem 2014, 25(4):404-411.
23. Wu T., Tang Q., Yu Z., Gao Z., Hu H., Chen W., et al. Inhibitory effects of sweet cherry anthocyanins on the obesity development in C57BL/6 mice. Int J Food Sci Nutr 2014, 65(3):351-359.
24. Alvarez-Suarez J.M., Giampieri F., Tulipani S., Casoli T., Di Stefano G., González-Paramás A.M., et al. One-month strawberry-rich anthocyanin supplementation ameliorates cardiovascular risk, oxidative stress markers and platelet activation in humans. J Nutr Biochem 2014, 25(3):289-294.
25. Rodes L., Khan A., Paul A., Coussa-Charley M., Marinescu D., Tomaro-Duchesneau C., et al. Effect of probiotics Lactobacillus and Bifidobacterium on gut-derived lipopolysaccharides and inflammatory cytokines: an in vitro study using a human colonic microbiota model. J Microbiol Biotechnol 2013, 23(4):518-526.
26. Ghoshal S., Witta J., Zhong J., de Villiers W., Eckhardt E. Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res 2009, 50(1):90-97.
27. Caricilli A.M., Saad M.J. The role of gut microbiota on insulin resistance. Nutrients 2013, 5(3):829-851.
28. Le Dréan G., Haure-Mirande V., Ferrier L., Bonnet C., Hulin P., de Coppet P., et al. Visceral adipose tissue and leptin increase colonic epithelial tight junction permeability via a RhoA-ROCK-dependent pathway. FASEB J 2014, 28(3):1059-1070.
29. Million M., Angelakis E., Paul M., Armougom F., Leibovici L., Raoult D. Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals. Microb Pathog 2012, 53(2):100-108.
30. Takeda K., Akira S. TLR signaling pathways. Semin Immunol 2004, 16(1):3-9.
31. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124(4):783-801.
32. Kumar H., Kawai T., Akira S. Toll-like receptors and innate immunity. Biochem Biophys Res Commun 2009, 388(4):621-625.
33. Ferreira C.M., Vieira A.T., Vinolo M.A., Oliveira F.A., Curi R., Martins F dos S. The central role of the gut microbiota in chronic inflammatory diseases. J Immunol Res 2014, 2014:12.
34. Kamada N., Núñez G. Regulation of the immune system by the resident intestinal bacteria. Gastroenterology 2014, 146(6):1477-1488.
35. Kamada N., Seo S.U., Chen G.Y., Núñez G. Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol 2013, 13:321-335.
36. Hooper L.V., Macpherson A.J. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 2010, 10:159-169.
37. Flint H.J., Scott K.P., Duncan S.H., Louis P., Forano E. Microbial degradation of complex carbohydrates in the gut. Gut Microbes 2012, 3(4):289-306.
38. Qin J., Li R., Raes J., Arumugam M., Burgdorf K.S., Manichanh C., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464(7285):59-65.
39. Karlsson C.L., Molin G., Fåk F., Johansson Hagslätt M.L., Jakesevic M., Håkansson Å., et al. Effects on weight gain and gut microbiota in rats given bacterial supplements and a high-energy-dense diet from fetal life through to 6 months of age. Br J Nutr 2011, 106(6):887-895.
40. Cani P.D., Bibiloni R., Knauf C., Waget A., Neyrinck A.M., Delzenne N.M., et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008, 57(6):1470-1481.
41. Cani P.D., Possemiers S., Van de Wiele T., Guiot Y., Everard A., Rottier O., et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009, 58(8):1091-1103.
42. Hamada K., Kakigawa N., Sekine S., Shitara Y., Horie T. Disruption of ZO-1/claudin-4 interaction in relation to inflammatory responses in methotrexate-induced intestinal mucositis. Cancer Chemother Pharmacol 2013, 72(4):757-765.
43. Paris L., Tonutti L., Vannini C., Bazzoni G. Structural organization of the tight junctions. Biochim Biophys Acta 2008, 1778(3):646-659.
44. Van Itallie C.M., Anderson J.M. Claudins and epithelial paracellular transport. Annu Rev Physiol 2006, 68:403-429.
45. Ménard S., Cerf-Bensussan N., Heyman M. Multiple facets of intestinal permeability and epithelial handling of dietary antigens. Mucosal Immunol 2010, 3(3):247-259.
46. Hamada K., Shitara Y., Sekine S., Horie T. Zonula occludens-1 alterations and enhanced intestinal permeability in methotrexate-treated rats. Cancer Chemother Pharmacol 2010, 66(6):1031-1038.
47. Caricilli A.M., Picardi P.K., de Abreu L.L., Ueno M., Prada P.O., Ropelle E.R., et al. Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice. PLoS Biol 2011, 9(12):e1001212.
48. Donato K.A., Zareie M., Jassem A.N., Jandu N., Alingary N., Carusone S.C., et al. Escherichia albertii and Hafnia alvei are candidate enteric pathogens with divergent effects on intercellular tight junctions. Microb Pathog 2008, 45(5-6):377-385.
49. Wang F., Graham W.V., Wang Y., Witkowski E.D., Schwarz B.T., Turner J.R. Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am J Pathol 2005, 166(2):409-419.
50. Donato K.A., Gareau M.G., Wang Y.J., Sherman P.M. Lactobacillus rhamnosus GG attenuates interferon-y and tumor necrosis factor-alpha-induced barrier dysfunction and pro-inflammatory signalling. Microbiology 2010, 156(Pt11):3288-3297.
51. D'Argenio G., Cariello R., Tuccillo C., Mazzone G., Federico A., Funaro A., et al. Symbiotic formulation in experimentally induced liver fibrosis in rats: intestinal microbiota as a key point to treat liver damage?. Liver Int 2013, 33(5):687-697.
52. Greiner A.K., Papineni R.V., Umar S. Chemoprevention in gastrointestinal physiology and disease. Natural products and microbiome. Am J Physiol Gastrointest Liver Physiol 2014, 307(1):G1-G15.
53. Lee K., Paek K., Lee H.Y., Park J.H., Lee Y. Antiobesity effect of trans-10, cis-12-conjugated linoleic acid-producing Lactobacillus plantarum PL62 on diet-induced obese mice. J Appl Microbiol 2007, 103(4):1140-1146.
54. Amar J., Chabo C., Waget A., Klopp P., Vachoux C., Bermúdez-Humarán L.G., et al. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med 2011, 3(9):559-572.
55. Xu R.Y., Wan Y.P., Fang Q.Y., Lu W., Cai W. Supplementation with probiotics modifies gut flora and attenuates liver fat accumulation in rat nonalcoholic fatty liver disease model. J Clin Biochem Nutr 2012, 50(1):72-77.
56. Arora T., Singh S., Sharma R.K. Probiotics: interaction with gut microbiome and antiobesity potential. Nutrition 2013, 29(4):591-596.
57. Delzenne N.M., Neyrinck A.M., Cani P.D. Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome. Microb Cell Fact 2011, 10(Suppl. 1):1-11. S10.
58. Wang J., Tang H., Zhang C., Zhao Y., Derrien M., Rocher E., et al. Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice. ISME J 2015, 9(1):1-15.
59. Orlando A., Linsalata M., Notarnicola M., Tutino V., Russo F. Lactobacillus GG restoration of the gliadin induced epithelial barrier disruption: the role of cellular polyamines. BMC Microbiol 2014, 14:14-19.
60. Ritze Y., Bárdos G., Claus A., Ehrmann V., Bergheim I., Schwiertz A., et al. Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice. PLoS One 2014, 9(1):e80169.
61. Rivollier A., He J., Kole A., Valatas V., Kelsall B.L. Inflammation switches the differentiation program of Ly6Chi monocytes from anti-inflammatory macrophages to inflammatory dendritic cells in the colon. J Exp Med 2012, 209:139-155.
62. da Silva N.A., Rodrigues E., Mercadante A.Z., de Rosso V.V. Phenolic compounds and carotenoids from four fruits native from the Brazilian Atlantic Forest. J Agric Food Chem 2014, 62(22):5072-5084.
63. Borges G.S.C., Vieira F.G.K., Copetti C., Gonzaga L.V., Zambiazi R.C., Filho J.M., et al. Chemical characterization, bioactive compounds, and antioxidant capacity of Jussara (Euterpe edulis) fruit from the atlantic forest in Southern Brazil. Food Res Int 2011, 44(7):2128-2133.
64. De Rosso V.V., Hillebrand S., Montilla E.C., Bobbio F.O., Winterhalter P., Mercadante A.Z. Determination of anthocyanins from Acerola (Malpighia emarginata DC.) and Açai (Euterpe oleracea Mart.) by HPLC-PDA and HPLC-MS. J Food Comp Anal 2008, 21(4):291-299.
65. Kay C.D. Aspects of anthocyanin absorption, metabolism and pharmacokinetics in humans. Nutr Res Rev 2006, 19(1):137-146.
66. Manach C., Williamson G., Morand C., Scalbert A., Rémésy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 2005, 81(1 Suppl.):230S-242S.
67. Zamora-Ros R., Knaze V., Luján-Barroso L., Slimani N., Romieu I., Touillaud M., et al. Estimation of the intake of anthocyanidins and their food sources in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Br J Nutr 2011, 106(7):1090-1099.
68. Bicudo M.O., Ribani R.H., Beta T. Anthocyanins, phenolic acids and antioxidant properties of Juçara fruits (Euterpe edulis M.) along the on-tree ripening process. Plant Foods Hum Nutr 2014, 69(2):142-147.
69. Silva P.P.M., Carmo L.F., Silva G.M., Silveira-Diniz M.F., Spoto M.H.F., Casemiro R.C. Physical, chemical, and lipid composition of jussara (Euterpe edulis mart.) pulp. Br J Food Nutr 2013, 24(1):7-13.
70. Bishayee A., Thoppil R.J., Mandal A., Darvesh A.S., Ohanyan V., Meszaros J.G., et al. Black currant phytoconstituents exert chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis by suppression of the inflammatory response. Mol Carcinog 2013, 52(4):304-317.
71. Lee B., Lee M., Lefevre M., Kim H.R. Anthocyanins inhibit lipogenesis during adipocyte differentiation of 3T3-L1 preadipocytes. Plant Foods Hum Nutr 2014, 69(2):137-141.
72. Song J., Zhao M., Liu X., Zhu Y., Hu X., Chen F. Protection of cyanidin-3-glucoside against oxidative stress induced by acrylamide in human MDA-MB-231 cells. Food Chem Toxicol 2013, 58:306-310.
73. de Souza M.O., Silva M., Silva M.E., Oliveira R de P., Pedrosa M.L. Diet supplementation with acai (Euterpe oleracea Mart.) pulp improves biomarkers of oxidative stress and the serum lipid profile in rats. Nutrition 2010, 26(7-8):804-810.
74. Noratto G.D., Angel-Morales G., Talcott S.T., Mertens-Talcott S.U. Polyphenolics from açaí (Euterpe oleracea Mart.) and red muscadine grape (Vitis rotundifolia) protect human umbilical vascular Endothelial cells (HUVEC) from glucose- and lipopolysaccharide (LPS)-induced inflammation and target microRNA-126. J Agric Food Chem 2011, 59(14):7999-8012.
75. Graf D., Seifert S., Bub A., Fröhling B., Dold S., Unger F., et al. Anthocyanin-rich juice does not affect gut-associated immunity in Fischer rats. Mol Nutr Food Res 2013, 57(10):1753-1761.
76. Hassimotto N.M., Genovese M.I., Lajolo F.M. Absorption and metabolism of cyanidin-3-glucoside and cyanidin-3-rutinoside extracted from wild mulberry (Morus nigra L.) in rats. Nutr Res 2008, 28(3):198-207.
77. Mertens-Talcott S.U., Rios J., Jilma-Stohlawetz P., Pacheco-Palencia L.A., Meibohm B., Talcott S.T., et al. Pharmacokinetics of anthocyanins and antioxidant effects after the consumption of anthocyanin-rich acai juice and pulp (Euterpe oleracea Mart.) in human healthy volunteers. J Agric Food Chem 2008, 56(17):7796-7802.
78. Talavéra S., Felgines C., Texier O., Besson C., Gil-Izquierdo A., Lamaison J.L., et al. Anthocyanin metabolism in rats and their distribution to digestive area, kidney, and brain. J Agric Food Chem 2005, 53(10):3902-3908.
79. Faria A., Fernandes I., Norberto S., Mateus N., Calhau C. Interplay between anthocyanins and gut microbiota. J Agric Food Chem 2014, 62(29):6898-6902.
80. Boto-Ordóñez M., Urpi-Sarda M., Queipo-Ortuño M.I., Tulipani S., Tinahones F.J., Andres-Lacueva C. High levels of Bifidobacteria are associated with increased levels of anthocyanin microbial metabolites: a randomized clinical trial. Food Funct 2014, 5(8):1932-1938.
81. Morais C.A., Oyama L.M., de Oliveira J.L., Garcia M.C., de Rosso V.V., Amigo L.S.M., et al. Jussara (Euterpe edulis Mart.) supplementation during pregnancy and lactation modulates the gene and protein expression of inflammation biomarkers induced by trans-fatty acids in the colon of offspring. Mediators Inflamm 2014, 2014:11.
82. Morais C.A., Oyama L.M., Conrado R.M., de Rosso V.V., Oller do Nacimento C., Pisani L.P. Polyphenols-rich fruit in maternal diet modulates inflammatory markers and the gut microbiota and improves colonic expression of ZO-1 in offspring. Food Res Int 2015, [in press].